Cikakken Bayani
Hankalin Dangi: 96.97% (95% CI: 83.35% ~ 99.99%)
Ƙimar Dangi: 100.00% (95% CI: 97.29% ~ 100.00%)
Daidaici: 99.50% (95% CI: 96.94% ~ 99.99%)
Marufi & Bayarwa
| Cikakken bayanin marufi: daidaitaccen fakitin fitarwa Bayanin isarwa: a cikin kwanakin aiki 7-10 bayan an karɓi biyan kuɗi |
Ƙayyadaddun bayanai
Kayan gwajin sauri na Lepu Rapid AMRDT120 na siyarwa
Gwaji mai sauri don gano ƙwararru na neutralizing
rigakafi ga SARS-CoV-2 ko alluran rigakafinta a cikin jini gaba ɗaya, jini, ko plasma.
Ƙimar Kunshin: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.
Hankalin Dangi: 96.97% (95% CI: 83.35% ~ 99.99%)
Ƙimar Dangi: 100.00% (95% CI: 97.29% ~ 100.00%)
Daidaici: 99.50% (95% CI: 96.94% ~ 99.99%)
Jakunkuna, tare da cassstetes gwaji da desiccants *20
Assay buffer * 20 vials;
Matsalolin da ake zubarwa *20;
Lancet*20
Lodine swab*20
Umarnin don amfani*1
Kayan gwajin sauri na Lepu AMRDT120 NUFIN AMFANI
Gwajin gaggawa na SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) shine saurin immunoassay na chromatographic don gano ingantattun ƙwayoyin rigakafi zuwa SARS-CoV-2 a cikin jini gaba ɗaya, magani, ko plasma.
Kayan gwajin sauri na Lepu Rapid AMRDT120 PRINCIPLE
Gwajin gaggawa na SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) don gano ƙwayoyin rigakafi ne ga SARS-CoV-2 ko rigakafin sa.Mai karɓar mai karɓar angiotensin yana canza enzyme-2 (ACE2) an rufe shi a cikin yankin layin gwaji da yanki mai ɗaure mai karɓa (RBD) tare da abubuwan da ke nuna.
Yayin gwaji, idan akwai ƙwayoyin rigakafi na SARS-CoV-2 a cikin samfurin, zai amsa tare da furotin RBD-barbashi mai haɗin gwiwa kuma ba zai amsa da furotin da aka riga aka rufa ba ACE2.Cakuda daga nan yana ƙaura zuwa sama akan membrane chromatographically ta aikin capillary kuma ba zai kama shi da antigen da aka riga aka rufa ba.Gwajin gaggawa na SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) yana ƙunshe da barbashi mai rufaffiyar furotin RBD.Sunadaran ACE2 an lullube su a yankin layin gwaji.
